1 |
(-)-epicatechin |
Epicatechin |
- |
- |
- |
086 [2] 86, 113 💬 |
2 |
(pyr1)apelin-13 |
- |
- |
- |
- |
086 [1] 86 💬 |
3 |
(s)-2-(4,6-dimethylpyrimidin-2-yloxy)-3-methoxy-3,3-diphenylpropanoic acid |
- |
- |
- |
- |
086 [1] 86 💬 |
4 |
(s)-3-((3-(1-((6-(3,4-dimethoxyphenyl)pryazin-2-yl)amino)ethyl)phenyl)carbamoyl)-5-methylpridin-1-ium |
- |
- |
- |
- |
086 [1] 86 💬 |
5 |
**comment**- imp inhalation solution identical to ventavis inhalation solution, but imp is in a different volume presentation. please see covering letter. |
- |
- |
- |
- |
086 [1] 86 💬 |
6 |
10-nitro-9(e)-octadec-9-enoic acid |
- |
- |
- |
- |
086 [1] 86 💬 |
7 |
11c-acetate |
Acetate |
- |
- |
- |
013 [3] 13, 86, 88 💬 |
8 |
120 mg sodium nitrite inhalation solution |
Nitrite |
- |
- |
- |
086 [1] 86 💬 |
9 |
15 mg sodium nitrite inhalation solution |
Nitrite |
- |
- |
- |
086 [1] 86 💬 |
10 |
150mg cxa-10 |
CXA-10 |
- |
- |
- |
086 [1] 86 💬 |
11 |
171 |
- |
- |
- |
- |
086 [1] 86 💬 |
12 |
2-(4-[5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy)-n-(methylsulfonyl)actamide |
- |
- |
- |
- |
086 [1] 86 💬 |
13 |
2-{4-[(5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy}-n-(methylsulfonyl) acetamide |
Acetamide |
- |
- |
- |
086 [1] 86 💬 |
14 |
20 mg sildenafil citrate by mouth |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
15 |
25% mtd sodium nitrite inhalation solution |
Nitrite |
- |
- |
- |
086 [1] 86 💬 |
16 |
45 mg sodium nitrite inhalation solution |
Nitrite |
- |
- |
- |
086 [1] 86 💬 |
17 |
4au76 |
- |
- |
- |
- |
086 [1] 86 💬 |
18 |
66215-101 |
- |
- |
- |
- |
086 [1] 86 💬 |
19 |
6r-bh4 |
Sapropterin |
[1] D08505 D08505 💬 |
- |
- |
086 [3] 86, 124, 240 💬 |
20 |
75mg cxa-10 |
CXA-10 |
- |
- |
- |
086 [1] 86 💬 |
21 |
90 mg sodium nitrite inhalation solution |
Nitrite |
- |
- |
- |
086 [1] 86 💬 |
22 |
: 2-{4-[(5,6-difenilpirazin-2-yl)(isopropil)amino]butoxi}-n- |
- |
- |
- |
- |
086 [1] 86 💬 |
23 |
[11c]-gsk2256098 500 mbq |
GSK2256098 |
- |
- |
- |
086 [1] 86 💬 |
24 |
[18f] fes |
- |
- |
- |
- |
086 [1] 86 💬 |
25 |
[18f]fluoro-2-deoxy-2-d-glucose |
D-glucose |
[1] D00009 D00009 💬 |
- |
- |
086 [2] 86, 88 💬 |
26 |
Abi-009, nab-rapamycin, albumin-bound rapamycin |
Sirolimus |
[1] D00753 D00753 💬 |
MTOR [1] MTOR 💬 |
AMPK signaling pathway [50] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
086 [1] 86 💬 |
27 |
Access program - sildenafil citrate, viagra, revatio |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
28 |
Ace-011 |
- |
- |
- |
- |
086 [1] 86 💬 |
29 |
Acetamide |
Acetamide |
- |
- |
- |
086 [1] 86 💬 |
30 |
Acetaminophen |
Acetaminophen |
[1] D00217 D00217 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
011 [14] 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬 |
31 |
Acetate |
Acetate |
- |
- |
- |
001 [43] 1 , 2 , 6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬 |
32 |
Act - 064992 |
- |
- |
- |
- |
086 [1] 86 💬 |
33 |
Act-050089 |
- |
- |
- |
- |
086 [1] 86 💬 |
34 |
Act-050089 (ro 61-0612) |
- |
- |
- |
- |
086 [1] 86 💬 |
35 |
Act-064992 |
- |
- |
- |
- |
051 [5] 51, 85, 86, 88, 210 💬 |
36 |
Act-064992d |
- |
- |
- |
- |
086 [1] 86 💬 |
37 |
Act-178418 |
- |
- |
- |
- |
086 [1] 86 💬 |
38 |
Act-293987 |
- |
- |
- |
- |
051 [3] 51, 86, 88 💬 |
39 |
Act-293987 (ns-304) |
- |
- |
- |
- |
086 [1] 86 💬 |
40 |
Act-385781a |
- |
- |
- |
- |
086 [1] 86 💬 |
41 |
Act-385781a (actelion epoprostenol) |
Epoprostenol |
[2] D00106 D00106, D01337 D01337 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
42 |
Actriia-igg1fc |
- |
- |
- |
- |
086 [1] 86 💬 |
43 |
Adcirca |
- |
- |
- |
- |
086 [1] 86 💬 |
44 |
Adcirca 20 mg film-coated tablets |
- |
- |
- |
- |
086 [1] 86 💬 |
45 |
Adcirca® |
- |
- |
- |
- |
086 [1] 86 💬 |
46 |
Adempas |
- |
- |
- |
- |
051 [5] 51, 86, 88, 225, 299 💬 |
47 |
Adempas (riociguat, bay63-2521) |
Riociguat |
[1] D09572 D09572 💬 |
GUCY1A1 [3] GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment [11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
086 [2] 86, 88 💬 |
48 |
Adempas - 0,5 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse |
- |
- |
- |
- |
086 [1] 86 💬 |
49 |
Adempas - 1 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse |
- |
- |
- |
- |
051 [2] 51, 86 💬 |
50 |
Adempas - 1,5 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse |
- |
- |
- |
- |
051 [2] 51, 86 💬 |
51 |
Adempas - 2 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse |
- |
- |
- |
- |
051 [2] 51, 86 💬 |
52 |
Adempas - 2,5 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse |
- |
- |
- |
- |
051 [2] 51, 86 💬 |
53 |
Adempas 0.5 mg |
- |
- |
- |
- |
086 [2] 86, 299 💬 |
54 |
Adempas 0.5 mg film coated tablet |
- |
- |
- |
- |
086 [1] 86 💬 |
55 |
Adempas 1 mg film coated tablet |
- |
- |
- |
- |
086 [1] 86 💬 |
56 |
Adempas 1.0 mg |
- |
- |
- |
- |
086 [2] 86, 299 💬 |
57 |
Adempas 1.5 mg |
- |
- |
- |
- |
086 [1] 86 💬 |
58 |
Adempas 1.5 mg film coated tablet |
- |
- |
- |
- |
086 [1] 86 💬 |
59 |
Adempas 2 mg film coated tablet |
- |
- |
- |
- |
086 [1] 86 💬 |
60 |
Adempas 2.0 mg |
- |
- |
- |
- |
086 [2] 86, 299 💬 |
61 |
Adempas 2.5 mg |
- |
- |
- |
- |
086 [1] 86 💬 |
62 |
Adempas 2.5 mg film coated tablet |
- |
- |
- |
- |
086 [1] 86 💬 |
63 |
Adempas® |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
64 |
Adempas® 0.5 mg film-coated tablets |
- |
- |
- |
- |
086 [1] 86 💬 |
65 |
Adempas® 1.0 mg film-coated tablets |
- |
- |
- |
- |
086 [1] 86 💬 |
66 |
Adempas® 1.5 mg film-coated tablets |
- |
- |
- |
- |
086 [1] 86 💬 |
67 |
Adempas® 2.0 mg film-coated tablets |
- |
- |
- |
- |
086 [1] 86 💬 |
68 |
Adempas® 2.5 mg film-coated tablets |
- |
- |
- |
- |
086 [1] 86 💬 |
69 |
Adempas¿ 0.5 mg compressa rivestita con film |
- |
- |
- |
- |
086 [1] 86 💬 |
70 |
Adempas¿ 1.0 |
- |
- |
- |
- |
086 [1] 86 💬 |
71 |
Adempas¿ 1.5 mg |
- |
- |
- |
- |
086 [1] 86 💬 |
72 |
Adempas¿ 2.0 mg |
- |
- |
- |
- |
086 [1] 86 💬 |
73 |
Adempas¿ 2.5 mg |
- |
- |
- |
- |
086 [1] 86 💬 |
74 |
Adipose derived mesenchymal stem cells |
- |
- |
- |
- |
086 [1] 86 💬 |
75 |
Aerosolized iloprost |
Iloprost |
[1] D02721 D02721 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
76 |
Air001 |
- |
- |
- |
- |
086 [1] 86 💬 |
77 |
Air001 (sodium nitrite inhalation solution) |
Nitrite |
- |
- |
- |
086 [1] 86 💬 |
78 |
Air001 inhalation solution |
- |
- |
- |
- |
086 [1] 86 💬 |
79 |
Air001 inhalation solution (expansion arm) |
- |
- |
- |
- |
086 [1] 86 💬 |
80 |
Al |
- |
- |
- |
- |
005 [9] 5 , 6 , 7 , 28, 51, 67, 86, 114, 127 💬 |
81 |
Albuterol |
Salbutamol |
[1] D02147 D02147 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
012 [8] 12, 13, 86, 89, 113, 231, 256, 299 💬 |
82 |
Albuterol first |
Salbutamol |
[1] D02147 D02147 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
83 |
Albuterol. |
Salbutamol |
[1] D02147 D02147 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
84 |
Allogeneic human cardiosphere-derived stem cells |
- |
- |
- |
- |
086 [1] 86 💬 |
85 |
Ambrisentan |
Ambrisentan |
[1] D07077 D07077 💬 |
EDNRA [1] EDNRA 💬 |
Calcium signaling pathway [7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 [7] 51, 84, 85, 86, 88, 210, 211 💬 |
86 |
Ambrisentan - high dose |
Ambrisentan |
[1] D07077 D07077 💬 |
EDNRA [1] EDNRA 💬 |
Calcium signaling pathway [7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
87 |
Ambrisentan - low dose |
Ambrisentan |
[1] D07077 D07077 💬 |
EDNRA [1] EDNRA 💬 |
Calcium signaling pathway [7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
88 |
Ambrisentan 5 mg film-coated tablets |
Ambrisentan |
[1] D07077 D07077 💬 |
EDNRA [1] EDNRA 💬 |
Calcium signaling pathway [7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
89 |
Ambrisentan 5mg film-coated tablets [marketed product] |
Ambrisentan |
[1] D07077 D07077 💬 |
EDNRA [1] EDNRA 💬 |
Calcium signaling pathway [7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
90 |
Ambrisentan plus spironolactone |
Ambrisentan |
[2] D00443 D00443, D07077 D07077 💬 |
EDNRA [2] EDNRA, NR3C2 💬 |
Aldosterone-regulated sodium reabsorption [8] Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
91 |
Ambrisentan tablet |
Ambrisentan |
[1] D07077 D07077 💬 |
EDNRA [1] EDNRA 💬 |
Calcium signaling pathway [7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
92 |
Ammonia |
Ammonia |
[1] D02916 D02916 💬 |
- |
- |
006 [4] 6 , 17, 86, 88 💬 |
93 |
Amn107 |
- |
- |
- |
- |
034 [2] 34, 86 💬 |
94 |
Anakinra |
Anakinra |
[1] D02934 D02934 💬 |
IL1R1 [2] IL1R1, IL1R2 💬 |
Amoebiasis [15] Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer |
002 [17] 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 84, 86, 97, 106, 107, 299 💬 |
95 |
Anastrozole |
Anastrozole |
[1] D00960 D00960 💬 |
CYP19A1 [1] CYP19A1 💬 |
Metabolic pathways [3] Metabolic pathways, Ovarian steroidogenesis, Steroid hormone biosynthesis |
078 [3] 78, 86, 193 💬 |
96 |
Angiotensin |
Angiotensin II |
[2] D00150 D00150, D02014 D02014 💬 |
AGTR1 [2] AGTR1, AGTR2 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
017 [7] 17, 19, 46, 66, 86, 222, 224 💬 |
97 |
Apabetalone |
Apabetalone |
[1] D11131 D11131 💬 |
- |
- |
086 [1] 86 💬 |
98 |
Apd811 |
- |
- |
- |
- |
086 [1] 86 💬 |
99 |
Apelin |
- |
- |
- |
- |
086 [1] 86 💬 |
100 |
Apn01 |
Recombinant Human Angiotensin-Converting Enzyme 2 |
- |
- |
- |
086 [1] 86 💬 |
101 |
Ar392830 |
- |
- |
- |
- |
086 [1] 86 💬 |
102 |
Aspirin |
Acetylsalicylic acid |
[1] D00109 D00109 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [11] 13, 22, 34, 46, 49, 51, 86, 113, 158, 210, 231 💬 |
103 |
Assigned pulmonary hypertension medication |
- |
- |
- |
- |
086 [1] 86 💬 |
104 |
Autologous epcs transfected |
- |
- |
- |
- |
086 [1] 86 💬 |
105 |
Autologous epcs transfected with human enos |
- |
- |
- |
- |
086 [1] 86 💬 |
106 |
Aviptadil |
Aviptadil |
- |
- |
- |
049 [4] 49, 51, 85, 86 💬 |
107 |
Azd4831 |
- |
- |
- |
- |
086 [1] 86 💬 |
108 |
Bardoxolone |
Bardoxolone |
[1] D09584 D09584 💬 |
- |
- |
066 [7] 66, 67, 84, 85, 86, 218, 222 💬 |
109 |
Bardoxolone methyl |
Bardoxolone |
[2] D09584 D09584, D09585 D09585 💬 |
- |
- |
066 [7] 66, 67, 84, 85, 86, 218, 222 💬 |
110 |
Bardoxolone methyl capsules |
Bardoxolone |
[2] D09584 D09584, D09585 D09585 💬 |
- |
- |
066 [4] 66, 67, 86, 222 💬 |
111 |
Bardoxolone methyl, cddo-me, cddo-methyl ester, nsc 713200, chemical name: oleana-1,9(11)-dien-28-oic acid, 2-cyano-3,12-dioxo-, methyl ester |
Bardoxolone |
[2] D09584 D09584, D09585 D09585 💬 |
- |
- |
086 [1] 86 💬 |
112 |
Bay 63-2521 |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
113 |
Bay 63-2521 0.06 % |
- |
- |
- |
- |
086 [1] 86 💬 |
114 |
Bay 63-2521 0.3 % |
- |
- |
- |
- |
086 [1] 86 💬 |
115 |
Bay 63-2521 coated tablets 0.5 mg |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
116 |
Bay 63-2521 coated tablets 1 mg |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
117 |
Bay 63-2521 coated tablets 1.5 mg |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
118 |
Bay 63-2521 coated tablets 2 mg |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
119 |
Bay 63-2521 coated tablets 2.5 mg |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
120 |
Bay 63-2521 ir tablets 0.5 mg |
- |
- |
- |
- |
086 [1] 86 💬 |
121 |
Bay 63-2521 ir tablets 1 mg |
- |
- |
- |
- |
086 [1] 86 💬 |
122 |
Bay 63-2521 ir tablets 1.0 mg |
- |
- |
- |
- |
086 [1] 86 💬 |
123 |
Bay 63-2521 ir tablets 1.5 mg |
- |
- |
- |
- |
086 [1] 86 💬 |
124 |
Bay 63-2521 ir tablets 2.0 mg |
- |
- |
- |
- |
086 [1] 86 💬 |
125 |
Bay 63-2521 ir tablets 2.5 mg |
- |
- |
- |
- |
086 [1] 86 💬 |
126 |
Bay 63-2521 tablet |
- |
- |
- |
- |
086 [1] 86 💬 |
127 |
Bay 63-2521 tablets 0.5 mg |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
128 |
Bay 63-2521 tablets 1 mg |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
129 |
Bay 63-2521 tablets 1.5 mg |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
130 |
Bay 63-2521 tablets 2 mg |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
131 |
Bay 63-2521 tablets 2.5 mg |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
132 |
Bay q 6256 |
- |
- |
- |
- |
086 [1] 86 💬 |
133 |
Bay1237592 |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
134 |
Bay63-2521 |
- |
- |
- |
- |
051 [3] 51, 86, 299 💬 |
135 |
Beetroot juice |
- |
- |
- |
- |
086 [1] 86 💬 |
136 |
Benzbromaron |
- |
- |
- |
- |
086 [1] 86 💬 |
137 |
Benzbromaron al |
- |
- |
- |
- |
086 [1] 86 💬 |
138 |
Benzbromarone |
Benzbromarone |
[1] D01056 D01056 💬 |
- |
- |
086 [1] 86 💬 |
139 |
Beraprost |
Beraprost |
[1] D02720 D02720 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
140 |
Beraprost sodium |
Beraprost |
[1] D02720 D02720 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
141 |
Beraprost sodium 314d modified release tablets |
Beraprost |
[1] D02720 D02720 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
142 |
Beraprost sodium modified release |
Beraprost |
[1] D02720 D02720 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
143 |
Bevacizumab |
Bevacizumab |
[1] D06409 D06409 💬 |
VEGFA [1] VEGFA 💬 |
AGE-RAGE signaling pathway in diabetic complications [22] AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway |
013 [9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬 |
144 |
Bh4 |
- |
- |
- |
- |
051 [5] 51, 86, 124, 240, 299 💬 |
145 |
Bia |
BIA |
- |
- |
- |
006 [2] 6 , 86 💬 |
146 |
Bia 5-1058 |
BIA |
- |
- |
- |
086 [1] 86 💬 |
147 |
Bia-5-1058 |
BIA |
- |
- |
- |
086 [1] 86 💬 |
148 |
Biological dmards |
- |
- |
- |
- |
086 [1] 86 💬 |
149 |
Bisoprolol |
Bisoprolol |
[2] D00634 D00634, D02342 D02342 💬 |
ADRB1 [1] ADRB1 💬 |
Adrenergic signaling in cardiomyocytes [10] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
067 [3] 67, 86, 113 💬 |
150 |
Blood test |
- |
- |
- |
- |
036 [5] 36, 86, 113, 162, 299 💬 |
151 |
Bosentan |
Bosentan |
[2] D01227 D01227, D07538 D07538 💬 |
EDNRA [2] EDNRA, EDNRB 💬 |
Calcium signaling pathway [9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 [11] 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬 |
152 |
Bosentan administration |
Bosentan |
[2] D01227 D01227, D07538 D07538 💬 |
EDNRA [2] EDNRA, EDNRB 💬 |
Calcium signaling pathway [9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
153 |
Bosentan and sildenafil |
Bosentan |
[4] D01227 D01227, D02229 D02229, D07538 D07538, D08514 D08514 💬 |
EDNRA [3] EDNRA, EDNRB, PDE5A 💬 |
Calcium signaling pathway [11] Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
154 |
Bosentan monohidrato |
Bosentan |
[2] D01227 D01227, D07538 D07538 💬 |
EDNRA [2] EDNRA, EDNRB 💬 |
Calcium signaling pathway [9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
155 |
Bosentan monohydrat |
Bosentan |
[2] D01227 D01227, D07538 D07538 💬 |
EDNRA [2] EDNRA, EDNRB 💬 |
Calcium signaling pathway [9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
156 |
Bosentan monohydrate |
Bosentan |
[2] D01227 D01227, D07538 D07538 💬 |
EDNRA [2] EDNRA, EDNRB 💬 |
Calcium signaling pathway [9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 [4] 51, 84, 86, 88 💬 |
157 |
Bosentan, ambrisentan |
Ambrisentan |
[3] D01227 D01227, D07077 D07077, D07538 D07538 💬 |
EDNRA [2] EDNRA, EDNRB 💬 |
Calcium signaling pathway [9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
158 |
Bps-314d-mr |
- |
- |
- |
- |
086 [1] 86 💬 |
159 |
Bps-mr |
- |
- |
- |
- |
086 [1] 86 💬 |
160 |
Bromure d'ipratropium |
Ipratropium |
[1] D02212 D02212 💬 |
CHRM1 [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Alzheimer disease [13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
086 [1] 86 💬 |
161 |
Bsf 208075 |
- |
- |
- |
- |
086 [1] 86 💬 |
162 |
Bsf 208075 or lu 208075 |
- |
- |
- |
- |
086 [1] 86 💬 |
163 |
C07ab07 |
- |
- |
- |
- |
086 [1] 86 💬 |
164 |
C225 |
- |
- |
- |
- |
051 [2] 51, 86 💬 |
165 |
Capsaicin |
Capsaicin |
[1] D00250 D00250 💬 |
TRPV1 [1] TRPV1 💬 |
Inflammatory mediator regulation of TRP channels [2] Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
002 [5] 2 , 6 , 19, 86, 226 💬 |
166 |
Captopril |
Captopril |
[1] D00251 D00251 💬 |
ACE [1] ACE 💬 |
Chagas disease [6] Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
017 [2] 17, 86 💬 |
167 |
Carbon |
Activated charcoal |
[1] D03251 D03251 💬 |
- |
- |
006 [9] 6 , 46, 50, 51, 85, 86, 96, 97, 298 💬 |
168 |
Carbon monoxide |
Activated charcoal |
[2] D03251 D03251, D09706 D09706 💬 |
- |
- |
085 [3] 85, 86, 298 💬 |
169 |
Carvedilol |
Carvedilol |
[2] D00255 D00255, D03415 D03415 💬 |
ADRA1A [5] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬 |
AMPK signaling pathway [12] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
006 [5] 6 , 57, 86, 113, 210 💬 |
170 |
Cetuximab |
Cetuximab |
[1] D03455 D03455 💬 |
EGFR [1] EGFR 💬 |
Adherens junction [46] Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis |
034 [5] 34, 51, 86, 89, 331 💬 |
171 |
Chlorhexidine |
Chlorhexidine |
[4] D00858 D00858, D01345 D01345, D03463 D03463, D07668 D07668 💬 |
- |
- |
086 [2] 86, 299 💬 |
172 |
Cialis |
- |
- |
- |
- |
051 [2] 51, 86 💬 |
173 |
Cialis 10 mg film-coated tablets |
- |
- |
- |
- |
086 [2] 86, 113 💬 |
174 |
Cialis 2.5 mg film-coated tablets |
- |
- |
- |
- |
086 [2] 86, 113 💬 |
175 |
Cialis 20 mg comprimidos recubiertos con película |
- |
- |
- |
- |
086 [1] 86 💬 |
176 |
Cialis 20 mg film-coated tablets |
- |
- |
- |
- |
086 [2] 86, 113 💬 |
177 |
Cialis 5 mg film-coated tablets |
- |
- |
- |
- |
086 [2] 86, 113 💬 |
178 |
Cicletanine |
Cicletanine |
[1] D03487 D03487 💬 |
- |
- |
086 [1] 86 💬 |
179 |
Cicletanine hydrochloride |
Cicletanine |
[1] D03487 D03487 💬 |
- |
- |
086 [1] 86 💬 |
180 |
Citrulline |
Citrulline |
[1] D07706 D07706 💬 |
- |
- |
086 [2] 86, 113 💬 |
181 |
Cjnj-68150420-zzz-g001 (act- 064992d) |
- |
- |
- |
- |
086 [1] 86 💬 |
182 |
Cjnj-68150420-zzz-g001 (act-064992d) |
- |
- |
- |
- |
086 [1] 86 💬 |
183 |
Cjnj-68150420-zzz-g001(act-064992d) |
- |
- |
- |
- |
086 [1] 86 💬 |
184 |
Clopidogrel |
Clopidogrel |
[4] D00769 D00769, D07729 D07729, D10823 D10823, D10824 D10824 💬 |
P2RY12 [1] P2RY12 💬 |
Platelet activation [1] Platelet activation |
049 [2] 49, 86 💬 |
185 |
Coenzyme q-10 |
Ubidecarenone |
[1] D01065 D01065 💬 |
- |
- |
086 [1] 86 💬 |
186 |
Coenzyme q-10 in normal control subjects |
Ubidecarenone |
[1] D01065 D01065 💬 |
- |
- |
086 [1] 86 💬 |
187 |
Coenzyme q-10 in pulmonary hypertension subjects |
Ubidecarenone |
[1] D01065 D01065 💬 |
- |
- |
086 [1] 86 💬 |
188 |
Combination product: device: axially oscillating sphere dry powder inhaler (aos dpi) |
- |
- |
- |
- |
086 [1] 86 💬 |
189 |
Combination product: implantable system for remodulin (treprostinil) |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
190 |
Combination product: treprostinil via implanted pump |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
191 |
Commercial ventavis® (iloprost) |
Iloprost |
[1] D02721 D02721 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
192 |
Conivaptan |
Conivaptan |
[2] D01236 D01236, D07748 D07748 💬 |
AVPR1A [2] AVPR1A, AVPR2 💬 |
Calcium signaling pathway [5] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption |
086 [1] 86 💬 |
193 |
Conventional drug therapy(expectorant,bronchodilator) |
- |
- |
- |
- |
086 [1] 86 💬 |
194 |
Cosmofer |
- |
- |
- |
- |
086 [3] 86, 96, 97 💬 |
195 |
Current marketed flolan (epoprostenol sodium) |
Epoprostenol |
[2] D00106 D00106, D01337 D01337 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
196 |
Cxa-10 |
CXA-10 |
- |
- |
- |
086 [2] 86, 222 💬 |
197 |
D-glucose |
D-glucose |
[1] D00009 D00009 💬 |
- |
- |
049 [3] 49, 86, 88 💬 |
198 |
Device: breelib nebulizer |
- |
- |
- |
- |
086 [1] 86 💬 |
199 |
Device: crono five ambulatory pump |
- |
- |
- |
- |
086 [1] 86 💬 |
200 |
Device: endopat measurement |
- |
- |
- |
- |
086 [1] 86 💬 |
201 |
Device: generic dry powder inhaler |
- |
- |
- |
- |
086 [1] 86 💬 |
202 |
Device: i-neb aad system |
- |
- |
- |
- |
086 [1] 86 💬 |
203 |
Device: l606 inhalation system |
- |
- |
- |
- |
086 [1] 86 💬 |
204 |
Device: mhealth intervention |
- |
- |
- |
- |
086 [1] 86 💬 |
205 |
Device: usual care |
- |
- |
- |
- |
086 [1] 86 💬 |
206 |
Dhea |
Prasterone |
[1] D08409 D08409 💬 |
AR [3] AR, ESR1, ESR2 💬 |
Breast cancer [11] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway |
049 [3] 49, 86, 96 💬 |
207 |
Dhea tablet |
Prasterone |
[1] D08409 D08409 💬 |
AR [3] AR, ESR1, ESR2 💬 |
Breast cancer [11] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway |
086 [1] 86 💬 |
208 |
Diagnostic test: cardiac mri (gadolinium enhanced) |
Gadolinium |
- |
- |
- |
086 [1] 86 💬 |
209 |
Diagnostic test: cmri |
- |
- |
- |
- |
051 [2] 51, 86 💬 |
210 |
Diagnostic test: endogenous thrombin potential |
Thrombin |
[1] D00090 D00090 💬 |
- |
- |
086 [2] 86, 88 💬 |
211 |
Diagnostic test: light transmission aggregometry |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
212 |
Diagnostic test: pet-ct imaging with [89zr]-bevacizumab |
Bevacizumab |
[1] D06409 D06409 💬 |
VEGFA [1] VEGFA 💬 |
AGE-RAGE signaling pathway in diabetic complications [22] AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway |
086 [1] 86 💬 |
213 |
Diagnostic test: platelet function analyzer-100 |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
214 |
Diagnostic test: rotational thromboelastometry |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
215 |
Dichloroacetate |
Dichloroacetic acid |
- |
- |
- |
086 [1] 86 💬 |
216 |
Dichloroacetate sodium |
Dichloroacetic acid |
- |
- |
- |
086 [1] 86 💬 |
217 |
Dietanolamina de treprostinilo |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
218 |
Diltiazem |
Diltiazem |
[3] D00616 D00616, D03830 D03830, D07845 D07845 💬 |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes [36] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 [3] 51, 58, 86 💬 |
219 |
Diltiazem hydrochloride |
Diltiazem |
[3] D00616 D00616, D03830 D03830, D07845 D07845 💬 |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes [36] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
220 |
Dimethyl fumarate |
Dimethyl fumarate |
[1] D03846 D03846 💬 |
KEAP1 [1] KEAP1 💬 |
Fluid shear stress and atherosclerosis [4] Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquitin mediated proteolysis |
013 [4] 13, 51, 86, 296 💬 |
221 |
Dimethyl fumarate (dmf) |
Dimethyl fumarate |
[1] D03846 D03846 💬 |
KEAP1 [1] KEAP1 💬 |
Fluid shear stress and atherosclerosis [4] Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquitin mediated proteolysis |
013 [3] 13, 51, 86 💬 |
222 |
Diphenhydramine |
Diphenhydramine |
[6] D00300 D00300, D00669 D00669, D02419 D02419, D03285 D03285, D03360 D03360, D03854 D03854 💬 |
HRH1 [1] HRH1 💬 |
Calcium signaling pathway [3] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
011 [8] 11, 49, 51, 70, 86, 96, 222, 256 💬 |
223 |
Duo-therapy with sildenafil + bosentan |
Bosentan |
[4] D01227 D01227, D02229 D02229, D07538 D07538, D08514 D08514 💬 |
EDNRA [3] EDNRA, EDNRB, PDE5A 💬 |
Calcium signaling pathway [11] Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
224 |
Efi/act-385781a |
- |
- |
- |
- |
086 [1] 86 💬 |
225 |
Elafin |
Elafin |
- |
- |
- |
086 [1] 86 💬 |
226 |
Endothelin receptor antagonist therapy |
- |
- |
- |
- |
086 [1] 86 💬 |
227 |
Endothelin-3 |
- |
- |
- |
- |
086 [1] 86 💬 |
228 |
Enos transfected epcs will be delivered via a pa line |
- |
- |
- |
- |
086 [1] 86 💬 |
229 |
Epicatechin |
Epicatechin |
- |
- |
- |
086 [2] 86, 113 💬 |
230 |
Epoprostenol |
Epoprostenol |
[2] D00106 D00106, D01337 D01337 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
231 |
Epoprostenol for injection |
Epoprostenol |
[2] D00106 D00106, D01337 D01337 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
232 |
Epoprostenol sodico |
Epoprostenol |
[2] D00106 D00106, D01337 D01337 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
233 |
Epoprostenol sodium |
Epoprostenol |
[2] D00106 D00106, D01337 D01337 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
234 |
Epoprostenol-actelion |
Epoprostenol |
[2] D00106 D00106, D01337 D01337 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
235 |
Epoprostenolo per iniezione |
- |
- |
- |
- |
086 [1] 86 💬 |
236 |
Equal |
- |
- |
- |
- |
006 [5] 6 , 13, 67, 86, 230 💬 |
237 |
Era and pde-5i (sildenafil, tadalafil, bosentan, macitentan) |
Bosentan |
[6] D01227 D01227, D02008 D02008, D02229 D02229, D07538 D07538, D08514 D08514, D10135 D10135 💬 |
EDNRA [3] EDNRA, EDNRB, PDE5A 💬 |
Calcium signaling pathway [11] Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
238 |
Era as specific pah treatment |
- |
- |
- |
- |
086 [1] 86 💬 |
239 |
Erbitux |
- |
- |
- |
- |
051 [2] 51, 86 💬 |
240 |
Esomeprazole |
Esomeprazole |
[4] D01984 D01984, D04056 D04056, D07917 D07917, D09339 D09339 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
013 [6] 13, 46, 86, 98, 298, 299 💬 |
241 |
Esr-specific pet scan |
- |
- |
- |
- |
086 [1] 86 💬 |
242 |
Esuberaprost |
- |
- |
- |
- |
086 [1] 86 💬 |
243 |
Eutonic treprostinil solution |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
244 |
Famotidine |
Famotidine |
[1] D00318 D00318 💬 |
HRH2 [1] HRH2 💬 |
Calcium signaling pathway [3] Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction |
006 [4] 6 , 46, 86, 98 💬 |
245 |
Famotidine 20 mg |
Famotidine |
[1] D00318 D00318 💬 |
HRH2 [1] HRH2 💬 |
Calcium signaling pathway [3] Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction |
086 [1] 86 💬 |
246 |
Fdc macitentan/tadalafil |
Macitentan |
[2] D02008 D02008, D10135 D10135 💬 |
EDNRA [3] EDNRA, EDNRB, PDE5A 💬 |
Calcium signaling pathway [11] Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
247 |
Ferinject |
- |
- |
- |
- |
086 [2] 86, 299 💬 |
248 |
Ferinject or cosmofer |
- |
- |
- |
- |
086 [1] 86 💬 |
249 |
Ferric carboxymaltose |
Ferric carboxymaltose |
[1] D08920 D08920 💬 |
- |
- |
086 [4] 86, 96, 97, 299 💬 |
250 |
Ferricarboxymaltose |
- |
- |
- |
- |
086 [1] 86 💬 |
251 |
Fk506 level 2-3 ng/ml |
- |
- |
- |
- |
086 [1] 86 💬 |
252 |
Fk506 level 3-5 ng/ml |
- |
- |
- |
- |
086 [1] 86 💬 |
253 |
Fk506 level < 2 ng/ml |
- |
- |
- |
- |
086 [1] 86 💬 |
254 |
Flolan |
- |
- |
- |
- |
086 [1] 86 💬 |
255 |
Flolan injection with currently marketed diluent |
- |
- |
- |
- |
086 [1] 86 💬 |
256 |
Flolan injection with reformulated diluent |
- |
- |
- |
- |
086 [1] 86 💬 |
257 |
Flolan tm and glycine diluent |
Glycine |
[1] D00011 D00011 💬 |
- |
- |
086 [1] 86 💬 |
258 |
Flolan® |
- |
- |
- |
- |
086 [1] 86 💬 |
259 |
Flolan™ and glycine diluent |
Glycine |
[1] D00011 D00011 💬 |
- |
- |
086 [1] 86 💬 |
260 |
Fluoxetine |
Fluoxetine |
[2] D00326 D00326, D00823 D00823 💬 |
SLC6A4 [1] SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
013 [4] 13, 17, 78, 86 💬 |
261 |
Fulvestrant |
Fulvestrant |
[1] D01161 D01161 💬 |
ESR1 [2] ESR1, ESR2 💬 |
Breast cancer [9] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
086 [1] 86 💬 |
262 |
G04be03 |
- |
- |
- |
- |
086 [1] 86 💬 |
263 |
G04be03- sildenafil - sildenafil (citrato) |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
264 |
Gadolinium |
Gadolinium |
- |
- |
- |
013 [6] 13, 34, 46, 58, 65, 86 💬 |
265 |
Gb002 |
- |
- |
- |
- |
086 [1] 86 💬 |
266 |
Gb002 capsules |
- |
- |
- |
- |
086 [1] 86 💬 |
267 |
Glivec |
- |
- |
- |
- |
051 [2] 51, 86 💬 |
268 |
Glivec 100 mg comprimidos recubiertos con película |
- |
- |
- |
- |
034 [2] 34, 86 💬 |
269 |
Glivec 100 mg filmtabletten |
- |
- |
- |
- |
051 [2] 51, 86 💬 |
270 |
Glivec 100 mg hartkapsel |
- |
- |
- |
- |
086 [1] 86 💬 |
271 |
Glivec® |
- |
- |
- |
- |
086 [1] 86 💬 |
272 |
Glivec® 100 mg filmtabletten |
- |
- |
- |
- |
086 [1] 86 💬 |
273 |
Glucose |
Dextrose, unspecified form |
- |
- |
- |
002 [15] 2 , 6 , 13, 49, 50, 65, 75, 86, 88, 96, 160, 195, 254, 257, 299 💬 |
274 |
Glycine |
Glycine |
[1] D00011 D00011 💬 |
- |
- |
035 [5] 35, 60, 86, 226, 299 💬 |
275 |
Gma301 injection |
- |
- |
- |
- |
086 [1] 86 💬 |
276 |
Gold |
Gold |
- |
- |
- |
002 [38] 2 , 5 , 6 , 13, 17, 34, 46, 49, 50, 53, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 158, 162, 171, 218, 222, 224, 227, 230, 271, 291, 294, 296, 298, 299, 310, 318 💬 |
277 |
Gradient |
- |
- |
- |
- |
058 [4] 58, 86, 149, 215 💬 |
278 |
Gs-4997 18 mg |
- |
- |
- |
- |
086 [1] 86 💬 |
279 |
Gs-4997 2 mg |
- |
- |
- |
- |
086 [1] 86 💬 |
280 |
Gs-4997 6 mg |
- |
- |
- |
- |
086 [1] 86 💬 |
281 |
Gsk1325760 |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
282 |
Gsk1325760a |
- |
- |
- |
- |
086 [1] 86 💬 |
283 |
Gsk2256098 |
GSK2256098 |
- |
- |
- |
086 [1] 86 💬 |
284 |
Gsk2586881 |
- |
- |
- |
- |
086 [1] 86 💬 |
285 |
Hgp1206 |
- |
- |
- |
- |
086 [1] 86 💬 |
286 |
Hydroxyurea |
Hydroxyurea |
[1] D00341 D00341 💬 |
RRM2 [1] RRM2 💬 |
Drug metabolism - other enzymes [6] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism, p53 signaling pathway |
003 [8] 3 , 13, 19, 20, 65, 85, 86, 284 💬 |
287 |
Hypotonictreprostinil solution |
- |
- |
- |
- |
086 [1] 86 💬 |
288 |
I.v. selexipag |
Selexipag |
[1] D09994 D09994 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
289 |
Ifetroban |
Ifetroban |
[1] D04500 D04500 💬 |
TBXA2R [1] TBXA2R 💬 |
Calcium signaling pathway [3] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Platelet activation |
051 [3] 51, 86, 113 💬 |
290 |
Ilomedin 20 |
- |
- |
- |
- |
086 [1] 86 💬 |
291 |
Ilomedin 20 [20 µg / ml] |
- |
- |
- |
- |
086 [1] 86 💬 |
292 |
Iloprost |
Iloprost |
[1] D02721 D02721 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 [4] 51, 84, 85, 86 💬 |
293 |
Iloprost (5 µg) |
Iloprost |
[1] D02721 D02721 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
294 |
Iloprost (ventavis bayq6256) |
Iloprost |
[1] D02721 D02721 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
295 |
Iloprost (ventavis inhaled, bayq6256) |
Iloprost |
[1] D02721 D02721 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
296 |
Iloprost (ventavis, bayq 6256) |
Iloprost |
[1] D02721 D02721 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
297 |
Iloprost (ventavis, bayq6256) |
Iloprost |
[1] D02721 D02721 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
298 |
Iloprost (ventavis®) |
Iloprost |
[1] D02721 D02721 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
299 |
Iloprost inhalation solution (ventavis) |
Iloprost |
[1] D02721 D02721 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
085 [2] 85, 86 💬 |
300 |
Iloprost pd-15 |
Iloprost |
[1] D02721 D02721 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
301 |
Iloprost pd-6 |
Iloprost |
[1] D02721 D02721 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
302 |
Iloprost,(ventavis, bayq6256) |
Iloprost |
[1] D02721 D02721 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
303 |
Imatinib |
Imatinib |
[2] D01441 D01441, D08066 D08066 💬 |
ABL1 [3] ABL1, KIT, PDGFRA 💬 |
Acute myeloid leukemia [31] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬 |
304 |
Imatinib mesilate |
Imatinib |
[2] D01441 D01441, D08066 D08066 💬 |
ABL1 [3] ABL1, KIT, PDGFRA 💬 |
Acute myeloid leukemia [31] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
013 [3] 13, 86, 88 💬 |
305 |
Imatinib mesylate |
Imatinib |
[2] D01441 D01441, D08066 D08066 💬 |
ABL1 [3] ABL1, KIT, PDGFRA 💬 |
Acute myeloid leukemia [31] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
013 [5] 13, 28, 34, 51, 86 💬 |
306 |
Inhaled dry powder treprostinil (liq861) |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
307 |
Inhaled iloprost (5 µg) |
Iloprost |
[1] D02721 D02721 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
308 |
Inhaled iloprost (ventavis, bayq6256) |
Iloprost |
[1] D02721 D02721 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
309 |
Inhaled nitric oxide |
Nitric Oxide |
[1] D00074 D00074 💬 |
- |
- |
085 [2] 85, 86 💬 |
310 |
Inhaled nitric oxide & inopulse delivery |
Nitric Oxide |
[1] D00074 D00074 💬 |
- |
- |
086 [1] 86 💬 |
311 |
Inhaled nitric oxide 75 mcg/kg ibw/hr |
Nitric Oxide |
[1] D00074 D00074 💬 |
- |
- |
085 [2] 85, 86 💬 |
312 |
Inhaled no with pulsed delivery |
- |
- |
- |
- |
086 [1] 86 💬 |
313 |
Inhaled prostacyclin |
Epoprostenol |
[2] D00106 D00106, D01337 D01337 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
314 |
Inhaled treprostinil |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
084 [2] 84, 86 💬 |
315 |
Ino |
- |
- |
- |
- |
085 [2] 85, 86 💬 |
316 |
Intravenous administration of ferric carboxymaltose |
Ferric carboxymaltose |
[1] D08920 D08920 💬 |
- |
- |
086 [1] 86 💬 |
317 |
Intravenous treprostinil |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
318 |
Intravenous/subcutaneous treprostinil |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
319 |
Ipratropium |
Ipratropium |
[1] D02212 D02212 💬 |
CHRM1 [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Alzheimer disease [13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
006 [2] 6 , 86 💬 |
320 |
Iron supplement |
- |
- |
- |
- |
086 [1] 86 💬 |
321 |
Jnj-67896049 |
- |
- |
- |
- |
086 [1] 86 💬 |
322 |
Jnj-67896049 (act-293987) |
- |
- |
- |
- |
086 [1] 86 💬 |
323 |
Jnj-67896062 / act-064992 |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
324 |
Jtt-251 |
- |
- |
- |
- |
086 [1] 86 💬 |
325 |
Kar5585 capsules |
- |
- |
- |
- |
086 [1] 86 💬 |
326 |
L-citrulline malate |
Citrulline |
[1] D07706 D07706 💬 |
- |
- |
086 [1] 86 💬 |
327 |
L606 (liposomal treprostinil) inhalation solution 51ug |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
328 |
Levitra |
- |
- |
- |
- |
013 [2] 13, 86 💬 |
329 |
Lidocaine |
Lidocaine |
[3] D00358 D00358, D02086 D02086, D08127 D08127 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
006 [10] 6 , 13, 34, 46, 51, 86, 168, 226, 231, 256 💬 |
330 |
Liq861 100 µg |
- |
- |
- |
- |
086 [1] 86 💬 |
331 |
Liq861 106 µg |
- |
- |
- |
- |
086 [1] 86 💬 |
332 |
Liq861 25 µg |
- |
- |
- |
- |
086 [1] 86 💬 |
333 |
Liq861 26.5 µg |
- |
- |
- |
- |
086 [1] 86 💬 |
334 |
Liq861 50 µg |
- |
- |
- |
- |
086 [1] 86 💬 |
335 |
Liq861 53 µg |
- |
- |
- |
- |
086 [1] 86 💬 |
336 |
Liq861 75 µg |
- |
- |
- |
- |
086 [1] 86 💬 |
337 |
Liq861 79.5 µg |
- |
- |
- |
- |
086 [1] 86 💬 |
338 |
Liq861 inhaled treprostinil |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
339 |
Lisuride |
Lisuride |
[2] D01462 D01462, D08132 D08132 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [2] 6 , 86 💬 |
340 |
Lloprost(ventavis,bayq6252, 10 µg/ml) |
- |
- |
- |
- |
086 [1] 86 💬 |
341 |
Lloprost(ventavis,bayq6252, 20 µg/ml) |
- |
- |
- |
- |
086 [1] 86 💬 |
342 |
Ly450190 |
- |
- |
- |
- |
086 [1] 86 💬 |
343 |
Macitentan |
Macitentan |
[1] D10135 D10135 💬 |
EDNRA [2] EDNRA, EDNRB 💬 |
Calcium signaling pathway [9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 [5] 51, 85, 86, 88, 210 💬 |
344 |
Macitentan (act-064992) |
Macitentan |
[1] D10135 D10135 💬 |
EDNRA [2] EDNRA, EDNRB 💬 |
Calcium signaling pathway [9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
345 |
Macitentan 10 mg |
Macitentan |
[1] D10135 D10135 💬 |
EDNRA [2] EDNRA, EDNRB 💬 |
Calcium signaling pathway [9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 [3] 51, 86, 88 💬 |
346 |
Macitentan 10 mg tablet, once daily. |
Macitentan |
[1] D10135 D10135 💬 |
EDNRA [2] EDNRA, EDNRB 💬 |
Calcium signaling pathway [9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
347 |
Macitentan 37.5 mg |
Macitentan |
[1] D10135 D10135 💬 |
EDNRA [2] EDNRA, EDNRB 💬 |
Calcium signaling pathway [9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
348 |
Macitentan 75 mg |
Macitentan |
[1] D10135 D10135 💬 |
EDNRA [2] EDNRA, EDNRB 💬 |
Calcium signaling pathway [9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
349 |
Macitentan group |
Macitentan |
[1] D10135 D10135 💬 |
EDNRA [2] EDNRA, EDNRB 💬 |
Calcium signaling pathway [9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
350 |
Macitentan tablets |
Macitentan |
[1] D10135 D10135 💬 |
EDNRA [2] EDNRA, EDNRB 💬 |
Calcium signaling pathway [9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [2] 86, 88 💬 |
351 |
Md-711 |
- |
- |
- |
- |
086 [1] 86 💬 |
352 |
Medical air |
Medical air |
- |
- |
- |
085 [3] 85, 86, 193 💬 |
353 |
Metformin |
Metformin |
[2] D00944 D00944, D04966 D04966 💬 |
PRKAA1 [2] PRKAA1, PRKAA2 💬 |
AMPK signaling pathway [19] AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
002 [21] 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬 |
354 |
Methyl 4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo |
- |
- |
- |
- |
086 [1] 86 💬 |
355 |
Methyl 4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo [3,4-b]pyridine-3-yl]-5-pyrimidinyl(methyl)carb |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
356 |
Methyl [4,6-diamino-2-[1-[(2-fluorophenyl)methyl]-1h-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]meth |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
357 |
Methylprednisolone |
Methylprednisolone |
[6] D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
002 [44] 2 , 6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬 |
358 |
Mk-5475 |
- |
- |
- |
- |
086 [1] 86 💬 |
359 |
Mk-8892 |
- |
- |
- |
- |
086 [1] 86 💬 |
360 |
Monitor |
Methamidophos |
- |
- |
- |
002 [18] 2 , 11, 13, 19, 46, 49, 58, 65, 70, 85, 86, 98, 113, 118, 129, 298, 299, 300 💬 |
361 |
Mono-therapy with sildenafil |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
362 |
Morphine |
Morphine |
[3] D00842 D00842, D02271 D02271, D08233 D08233 💬 |
OPRM1 [1] OPRM1 💬 |
Estrogen signaling pathway [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
036 [5] 36, 46, 70, 85, 86 💬 |
363 |
Morphine sulfate |
Morphine |
[3] D00842 D00842, D02271 D02271, D08233 D08233 💬 |
OPRM1 [1] OPRM1 💬 |
Estrogen signaling pathway [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
046 [3] 46, 85, 86 💬 |
364 |
Moxifloxacin |
Moxifloxacin |
[2] D00874 D00874, D08237 D08237 💬 |
- |
- |
002 [8] 2 , 6 , 46, 49, 85, 86, 240, 299 💬 |
365 |
Moxifloxacin 400 mg |
Moxifloxacin |
[2] D00874 D00874, D08237 D08237 💬 |
- |
- |
086 [1] 86 💬 |
366 |
Multihance |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
367 |
Nebulized combination ipratropium bromide with salbutamol |
Ipratropium |
[2] D02147 D02147, D02212 D02212 💬 |
ADRB2 [6] ADRB2, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Adrenergic signaling in cardiomyocytes [17] Adrenergic signaling in cardiomyocytes, Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
368 |
Nebulized ipratropium bromide |
Ipratropium |
[1] D02212 D02212 💬 |
CHRM1 [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Alzheimer disease [13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
086 [1] 86 💬 |
369 |
New thermo stable formulation of epoprostenol sodium |
Epoprostenol |
[2] D00106 D00106, D01337 D01337 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
370 |
Nicardipine |
Nicardipine |
[2] D00617 D00617, D08270 D08270 💬 |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes [36] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
070 [2] 70, 86 💬 |
371 |
Nilotinib |
Nilotinib |
[1] D08953 D08953 💬 |
ABL1 [4] ABL1, KIT, PDGFRA, PDGFRB 💬 |
Acute myeloid leukemia [32] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
006 [5] 6 , 8 , 34, 51, 86 💬 |
372 |
Nilotinib 50 mg |
Nilotinib |
[1] D08953 D08953 💬 |
ABL1 [4] ABL1, KIT, PDGFRA, PDGFRB 💬 |
Acute myeloid leukemia [32] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
086 [1] 86 💬 |
373 |
Nitric oxide |
Nitric Oxide |
[1] D00074 D00074 💬 |
- |
- |
046 [8] 46, 85, 86, 98, 210, 251, 294, 299 💬 |
374 |
Nitric oxide for inhalation |
Nitric Oxide |
[1] D00074 D00074 💬 |
- |
- |
086 [2] 86, 299 💬 |
375 |
Nitric oxide generated by the geno nitrosyl delivery system |
Nitric Oxide |
[1] D00074 D00074 💬 |
- |
- |
086 [1] 86 💬 |
376 |
Nitric oxide plus oxygen |
Nitric Oxide |
[2] D00003 D00003, D00074 D00074 💬 |
- |
- |
086 [1] 86 💬 |
377 |
Nitrite |
Nitrite |
- |
- |
- |
086 [2] 86, 299 💬 |
378 |
Nitrosyl |
Nitric Oxide |
[1] D00074 D00074 💬 |
- |
- |
086 [1] 86 💬 |
379 |
Non-biologic dmards |
- |
- |
- |
- |
046 [2] 46, 86 💬 |
380 |
Ns-304 |
- |
- |
- |
- |
070 [3] 70, 86, 88 💬 |
381 |
Null |
- |
- |
- |
- |
006 [16] 6 , 13, 15, 28, 37, 46, 49, 51, 63, 86, 90, 96, 97, 107, 145, 271 💬 |
382 |
Nx1011 |
- |
- |
- |
- |
086 [1] 86 💬 |
383 |
Observational study with patients treated with tracleer, ventavis, veletri, opsumit and/or uptravi |
- |
- |
- |
- |
086 [1] 86 💬 |
384 |
Olaparib |
Olaparib |
[1] D09730 D09730 💬 |
PARP1 [2] PARP1, PARP2 💬 |
Apoptosis [5] Apoptosis, Base excision repair, Diabetic cardiomyopathy, NF-kappa B signaling pathway, Necroptosis |
086 [2] 86, 285 💬 |
385 |
Opsumit |
- |
- |
- |
- |
086 [3] 86, 88, 210 💬 |
386 |
Opsumit (macitentan) |
Macitentan |
[1] D10135 D10135 💬 |
EDNRA [2] EDNRA, EDNRB 💬 |
Calcium signaling pathway [9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
387 |
Opsumit® |
- |
- |
- |
- |
086 [3] 86, 88, 210 💬 |
388 |
Oral anticoagulant treatment |
- |
- |
- |
- |
086 [1] 86 💬 |
389 |
Oral era |
- |
- |
- |
- |
086 [1] 86 💬 |
390 |
Oral ifetroban |
Ifetroban |
[1] D04500 D04500 💬 |
TBXA2R [1] TBXA2R 💬 |
Calcium signaling pathway [3] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Platelet activation |
051 [2] 51, 86 💬 |
391 |
Oral pde5 inhibitors |
- |
- |
- |
- |
086 [1] 86 💬 |
392 |
Oral selexipag (uptravi) |
Selexipag |
[1] D09994 D09994 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
393 |
Oral sildenafil |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
394 |
Oral treprostinil |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 [2] 51, 86 💬 |
395 |
Oral treprostinil (ut-15c) sustained release tablets |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
396 |
Other: iloprost (ventavis inhaled, bayq6256) |
Iloprost |
[1] D02721 D02721 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
397 |
Other: noninvasive actigraphy monitor |
Methamidophos |
- |
- |
- |
086 [1] 86 💬 |
398 |
Other: oxygen supplementation |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
086 [1] 86 💬 |
399 |
Other: standard-of-care |
- |
- |
- |
- |
086 [1] 86 💬 |
400 |
Other: standardized meals |
- |
- |
- |
- |
086 [1] 86 💬 |
401 |
Other: subacute hypoxic exposures |
- |
- |
- |
- |
086 [1] 86 💬 |
402 |
Oxygen |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
006 [18] 6 , 13, 19, 46, 49, 70, 84, 85, 86, 88, 90, 96, 97, 193, 226, 294, 299, 330 💬 |
403 |
Oxygen supplementation |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
086 [1] 86 💬 |
404 |
Oxygen, liquid |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
086 [2] 86, 88 💬 |
405 |
Pah |
- |
- |
- |
- |
049 [3] 49, 53, 86 💬 |
406 |
Pah medication |
- |
- |
- |
- |
086 [1] 86 💬 |
407 |
Parenteral remodulin (treprostinil) injection |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
408 |
Pb1046 |
- |
- |
- |
- |
086 [1] 86 💬 |
409 |
Pb1046 subcutaneous injection |
- |
- |
- |
- |
086 [1] 86 💬 |
410 |
Pb1046, vip-elp1-120, vasomera |
- |
- |
- |
- |
086 [1] 86 💬 |
411 |
Pemziviptadil (pb1046) |
- |
- |
- |
- |
086 [1] 86 💬 |
412 |
Pemziviptadil (pb1046) injection |
- |
- |
- |
- |
086 [1] 86 💬 |
413 |
Pf-00489791 |
PF-00489791 |
- |
- |
- |
086 [1] 86 💬 |
414 |
Ph-combination therapy |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
415 |
Ph-monotherapy |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
416 |
Pioglitazone |
Pioglitazone |
[2] D00945 D00945, D08378 D08378 💬 |
PPARG [1] PPARG 💬 |
AMPK signaling pathway [9] AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
002 [17] 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬 |
417 |
Placebo |
- |
- |
- |
- |
003 [26] 3 , 5 , 6 , 13, 14, 37, 40, 46, 49, 50, 51, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 💬 |
418 |
Plx-pad |
Placental Mesenchymal Stem Cells |
- |
- |
- |
086 [1] 86 💬 |
419 |
Prednisone |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
002 [47] 2 , 6 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬 |
420 |
Procedure: b-lines se |
- |
- |
- |
- |
058 [3] 58, 86, 215 💬 |
421 |
Procedure: coronary flow reserve se |
- |
- |
- |
- |
058 [3] 58, 86, 215 💬 |
422 |
Procedure: diastolic function se |
- |
- |
- |
- |
058 [3] 58, 86, 215 💬 |
423 |
Procedure: left ventricular contractile reserve se |
- |
- |
- |
- |
058 [3] 58, 86, 215 💬 |
424 |
Procedure: left ventricular outflow tract gradient se |
- |
- |
- |
- |
058 [3] 58, 86, 215 💬 |
425 |
Procedure: mitral regurgitation se |
- |
- |
- |
- |
058 [3] 58, 86, 215 💬 |
426 |
Procedure: no gas |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
427 |
Procedure: padn |
- |
- |
- |
- |
086 [1] 86 💬 |
428 |
Procedure: pulmonary hemodynamics se |
- |
- |
- |
- |
058 [3] 58, 86, 215 💬 |
429 |
Procedure: sham padn |
- |
- |
- |
- |
086 [1] 86 💬 |
430 |
Prostacyclin |
Epoprostenol |
[2] D00106 D00106, D01337 D01337 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
431 |
Puri-nethol |
- |
- |
- |
- |
086 [3] 86, 96, 97 💬 |
432 |
Q4w gma301 iv injections (1000 mg) |
- |
- |
- |
- |
086 [1] 86 💬 |
433 |
Q4w gma301 iv injections (300 mg) |
- |
- |
- |
- |
086 [1] 86 💬 |
434 |
Q4w gma301 iv injections (600 mg) |
- |
- |
- |
- |
086 [1] 86 💬 |
435 |
Qcc374 |
- |
- |
- |
- |
086 [1] 86 💬 |
436 |
Qcc374 0.015 mg |
- |
- |
- |
- |
086 [1] 86 💬 |
437 |
Qcc374 0.06 mg |
- |
- |
- |
- |
086 [1] 86 💬 |
438 |
Qti571 |
- |
- |
- |
- |
086 [1] 86 💬 |
439 |
Qutenza |
- |
- |
- |
- |
086 [1] 86 💬 |
440 |
Qutenza (8% capsaicin) |
Capsaicin |
[1] D00250 D00250 💬 |
TRPV1 [1] TRPV1 💬 |
Inflammatory mediator regulation of TRP channels [2] Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
086 [1] 86 💬 |
441 |
Radiation: pet/ct scan: two pet scans using 1. c-11 hed and 2. n-13 ammonia or rubidium-82 |
Ammonia |
[1] D02916 D02916 💬 |
- |
- |
086 [1] 86 💬 |
442 |
Ralinepag |
Ralinepag |
[1] D10725 D10725 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
443 |
Ranolazine |
Ranolazine |
[2] D05700 D05700, D05701 D05701 💬 |
- |
- |
002 [6] 2 , 58, 86, 96, 113, 114 💬 |
444 |
Rapamycin |
Sirolimus |
[1] D00753 D00753 💬 |
MTOR [1] MTOR 💬 |
AMPK signaling pathway [50] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
002 [18] 2 , 15, 34, 35, 46, 49, 51, 60, 61, 67, 86, 89, 96, 157, 158, 256, 278, 279 💬 |
445 |
Rapid dose titration group of subcutaneous treprostinil |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
446 |
Recombinant human angiotensin-converting enzyme 2 |
Angiotensin II |
[2] D00150 D00150, D02014 D02014 💬 |
AGTR1 [2] AGTR1, AGTR2 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
447 |
Recombinant human angiotensin-converting enzyme 2 (ace2), apn01 |
Angiotensin II |
[2] D00150 D00150, D02014 D02014 💬 |
AGTR1 [2] AGTR1, AGTR2 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
448 |
Remodulin |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
449 |
Remodulin (treprostinil sodium) |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
450 |
Remodulin® (treprostinil) 1 mg/ml solution for infusion |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
451 |
Remodulin® (treprostinil) 10 mg/ml solution for infusion |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
452 |
Remodulin® (treprostinil) 2.5 mg/ml solution for infusion |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
453 |
Remodulin® (treprostinil) 5 mg/ml solution for infusion |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
454 |
Revatio |
- |
- |
- |
- |
085 [3] 85, 86, 113 💬 |
455 |
Revatio 10 mg/ml powder for oral suspension |
- |
- |
- |
- |
086 [1] 86 💬 |
456 |
Revatio 20 mg film coated tablets |
- |
- |
- |
- |
086 [1] 86 💬 |
457 |
Revatio 20 mg film-coated tablets |
- |
- |
- |
- |
086 [1] 86 💬 |
458 |
Revatio 20 mg filmtabletten |
- |
- |
- |
- |
086 [1] 86 💬 |
459 |
Revatio 20 mg, comprimidos recubiertos con película |
- |
- |
- |
- |
086 [1] 86 💬 |
460 |
Revatio inyectable |
- |
- |
- |
- |
086 [1] 86 💬 |
461 |
Revatio oral |
- |
- |
- |
- |
086 [1] 86 💬 |
462 |
Revatio pos |
- |
- |
- |
- |
086 [1] 86 💬 |
463 |
Revatio tablets |
- |
- |
- |
- |
086 [1] 86 💬 |
464 |
Revatio ® 20 mg film-coated tablets |
- |
- |
- |
- |
086 [1] 86 💬 |
465 |
Revatio® |
- |
- |
- |
- |
086 [1] 86 💬 |
466 |
Riciguat group |
- |
- |
- |
- |
086 [1] 86 💬 |
467 |
Rifampin |
Rifampicin |
[1] D00211 D00211 💬 |
- |
- |
006 [5] 6 , 13, 84, 86, 299 💬 |
468 |
Riociguat |
Riociguat |
[1] D09572 D09572 💬 |
GUCY1A1 [3] GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment [11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
051 [6] 51, 84, 86, 88, 225, 299 💬 |
469 |
Riociguat (adempas, bay63-2521) |
Riociguat |
[1] D09572 D09572 💬 |
GUCY1A1 [3] GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment [11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
051 [4] 51, 86, 88, 299 💬 |
470 |
Riociguat (bay63-2521) |
Riociguat |
[1] D09572 D09572 💬 |
GUCY1A1 [3] GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment [11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
471 |
Riociguat granules 0.3% for oral application |
Riociguat |
[1] D09572 D09572 💬 |
GUCY1A1 [3] GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment [11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
472 |
Riociguat oral product |
Riociguat |
[1] D09572 D09572 💬 |
GUCY1A1 [3] GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment [11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
473 |
Riociguat pill |
Riociguat |
[1] D09572 D09572 💬 |
GUCY1A1 [3] GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment [11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
474 |
Ritonavir |
Ritonavir |
[1] D00427 D00427 💬 |
- |
- |
002 [3] 2 , 86, 265 💬 |
475 |
Rituximab |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
011 [47] 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬 |
476 |
Ro 47-0203 |
- |
- |
- |
- |
051 [4] 51, 85, 86, 88 💬 |
477 |
Ro 47-0203 / act-050088 |
- |
- |
- |
- |
086 [1] 86 💬 |
478 |
Ro-47-0203 |
- |
- |
- |
- |
086 [1] 86 💬 |
479 |
Ro-47-0203/029 |
- |
- |
- |
- |
086 [1] 86 💬 |
480 |
Ro47-0203 |
- |
- |
- |
- |
086 [1] 86 💬 |
481 |
Ro47-0203 / act-050088 |
- |
- |
- |
- |
051 [2] 51, 86 💬 |
482 |
Roactemra |
- |
- |
- |
- |
040 [9] 40, 41, 46, 51, 86, 107, 266, 271, 331 💬 |
483 |
Rt234 - vardenafil inhalation powder |
Vardenafil |
[3] D02731 D02731, D03260 D03260, D08668 D08668 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
484 |
Rta 402 |
- |
- |
- |
- |
067 [3] 67, 86, 218 💬 |
485 |
Rubidium |
Rubidium |
- |
- |
- |
084 [2] 84, 86 💬 |
486 |
Rvg 33865 |
- |
- |
- |
- |
086 [1] 86 💬 |
487 |
Rvt-1201 |
- |
- |
- |
- |
086 [1] 86 💬 |
488 |
Salbutamol |
Salbutamol |
[1] D02147 D02147 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
003 [9] 3 , 11, 49, 85, 86, 111, 228, 256, 299 💬 |
489 |
Saline |
- |
- |
- |
- |
006 [10] 6 , 13, 17, 53, 67, 78, 86, 97, 168, 299 💬 |
490 |
Sapropterin |
Sapropterin |
[1] D08505 D08505 💬 |
- |
- |
086 [3] 86, 124, 240 💬 |
491 |
Sapropterin dihydrochloride (6r-bh4) |
Sapropterin |
[1] D08505 D08505 💬 |
- |
- |
086 [1] 86 💬 |
492 |
Saquinavir |
Saquinavir |
[2] D00429 D00429, D01160 D01160 💬 |
- |
- |
086 [2] 86, 265 💬 |
493 |
Saquinavir and ritonavir |
Ritonavir |
[3] D00427 D00427, D00429 D00429, D01160 D01160 💬 |
- |
- |
086 [1] 86 💬 |
494 |
Sauerstoff |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
495 |
Selexipag |
Selexipag |
[1] D09994 D09994 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 [5] 51, 70, 84, 86, 88 💬 |
496 |
Selexipag (uptravi) |
Selexipag |
[1] D09994 D09994 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
497 |
Selexipag, act-293987 (ns-304) |
Selexipag |
[1] D09994 D09994 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
498 |
Selonsertib |
Selonsertib |
[1] D10988 D10988 💬 |
MAP3K5 [1] MAP3K5 💬 |
Alzheimer disease [17] Alzheimer disease, Amyotrophic lateral sclerosis, Apoptosis, Fluid shear stress and atherosclerosis, Huntington disease, MAPK signaling pathway, Neurotrophin signaling pathway, Non-alcoholic fatty liver disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Platinum drug resistance, Protein processing in endoplasmic reticulum, Sphingolipid signaling pathway, Spinocerebellar ataxia, TNF signaling pathway, Thermogenesis, Tight junction |
086 [1] 86 💬 |
499 |
Seralutinib |
- |
- |
- |
- |
086 [1] 86 💬 |
500 |
Serine |
Serine |
[1] D00016 D00016 💬 |
- |
- |
002 [3] 2 , 6 , 86 💬 |
501 |
Sham o2 (medical air) |
Medical air |
- |
- |
- |
086 [1] 86 💬 |
502 |
Sildenaf |
- |
- |
- |
- |
086 [1] 86 💬 |
503 |
Sildenafil |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
006 [17] 6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬 |
504 |
Sildenafil (as citrate) |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
505 |
Sildenafil (revatio) |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
506 |
Sildenafil (revatio) 20 mg tid |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
507 |
Sildenafil 20mg |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
051 [2] 51, 86 💬 |
508 |
Sildenafil 20mg and bosentan 62.5mg |
Bosentan |
[4] D01227 D01227, D02229 D02229, D07538 D07538, D08514 D08514 💬 |
EDNRA [3] EDNRA, EDNRB, PDE5A 💬 |
Calcium signaling pathway [11] Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 [2] 51, 86 💬 |
509 |
Sildenafil citrate |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
051 [4] 51, 85, 86, 225 💬 |
510 |
Sildenafil citrate (uk-92,480) |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
511 |
Sildenafil filmtabletten |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
512 |
Sildenafil singly or in association with bosentan |
Bosentan |
[4] D01227 D01227, D02229 D02229, D07538 D07538, D08514 D08514 💬 |
EDNRA [3] EDNRA, EDNRB, PDE5A 💬 |
Calcium signaling pathway [11] Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
513 |
Sildenafilo |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
514 |
Simvastatin |
Simvastatin |
[1] D00434 D00434 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
006 [21] 6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬 |
515 |
Simvastatin 40 mg |
Simvastatin |
[1] D00434 D00434 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
086 [1] 86 💬 |
516 |
Simvastatin 40 mg tablets |
Simvastatin |
[1] D00434 D00434 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
086 [1] 86 💬 |
517 |
Sitaxentan |
Sitaxentan |
[1] D07171 D07171 💬 |
EDNRA [1] EDNRA 💬 |
Calcium signaling pathway [7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
518 |
Sitaxentan sodium |
Sitaxentan |
[1] D07171 D07171 💬 |
EDNRA [1] EDNRA 💬 |
Calcium signaling pathway [7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
519 |
Sitaxsentan |
Sitaxentan |
[1] D07171 D07171 💬 |
EDNRA [1] EDNRA 💬 |
Calcium signaling pathway [7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
520 |
Sitaxsentan alone |
Sitaxentan |
[1] D07171 D07171 💬 |
EDNRA [1] EDNRA 💬 |
Calcium signaling pathway [7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
521 |
Sitaxsentan and sildenafil |
Sildenafil |
[3] D02229 D02229, D07171 D07171, D08514 D08514 💬 |
EDNRA [2] EDNRA, PDE5A 💬 |
Calcium signaling pathway [9] Calcium signaling pathway, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
522 |
Sitaxsentan sodium |
Sitaxentan |
[1] D07171 D07171 💬 |
EDNRA [1] EDNRA 💬 |
Calcium signaling pathway [7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
523 |
Slow dose titration group of subcutaneous treprostinil |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
524 |
Sodium nitrite |
Nitrite |
- |
- |
- |
086 [2] 86, 299 💬 |
525 |
Sodium nitrite inhalation solution |
Nitrite |
- |
- |
- |
086 [1] 86 💬 |
526 |
Sodium tanshinone iia sulfonate diluted with 5% glucose solution,20mg sildenafil citrate by mouth |
Dextrose, unspecified form |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
527 |
Sorafenib |
Sorafenib |
[2] D06272 D06272, D08524 D08524 💬 |
BRAF [8] BRAF, FLT3, FLT4, KDR, KIT, PDGFRB, RAF1, RET 💬 |
Acute myeloid leukemia [87] Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Central carbon metabolism in cancer, Chemokine signaling pathway, Choline metabolism in cancer, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, VEGF signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway |
034 [2] 34, 86 💬 |
528 |
Sotatercept |
Sotatercept |
[1] D09670 D09670 💬 |
ACVR2A [1] ACVR2A 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway |
086 [2] 86, 284 💬 |
529 |
Spironolactone |
Spironolactone |
[1] D00443 D00443 💬 |
NR3C2 [1] NR3C2 💬 |
Aldosterone-regulated sodium reabsorption [1] Aldosterone-regulated sodium reabsorption |
058 [7] 58, 67, 86, 113, 210, 218, 225 💬 |
530 |
Spironolactone and conivaptan |
Conivaptan |
[3] D00443 D00443, D01236 D01236, D07748 D07748 💬 |
AVPR1A [3] AVPR1A, AVPR2, NR3C2 💬 |
Aldosterone-regulated sodium reabsorption [6] Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption |
086 [1] 86 💬 |
531 |
Spironolactone captopril carvedilol |
Captopril |
[4] D00251 D00251, D00255 D00255, D00443 D00443, D03415 D03415 💬 |
ACE [7] ACE, ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2, NR3C2 💬 |
AMPK signaling pathway [18] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Dilated cardiomyopathy, Gap junction, Hypertrophic cardiomyopathy, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Renin-angiotensin system, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
532 |
Sti571 |
- |
- |
- |
- |
051 [2] 51, 86 💬 |
533 |
Subcutaneous and intravenous prostacyclin |
Epoprostenol |
[2] D00106 D00106, D01337 D01337 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
534 |
Subcutaneous treprostinil |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
535 |
Sugar pill |
- |
- |
- |
- |
005 [8] 5 , 6 , 49, 67, 70, 86, 206, 210 💬 |
536 |
Sulfasalazine |
Sulfasalazine |
[1] D00448 D00448 💬 |
- |
- |
046 [4] 46, 86, 94, 271 💬 |
537 |
Sulfate |
Sulfate ion |
- |
- |
- |
002 [25] 2 , 6 , 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 79, 85, 86, 96, 111, 222, 226, 265, 296, 297, 299 💬 |
538 |
Tadalafil |
Tadalafil |
[1] D02008 D02008 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
006 [7] 6 , 51, 75, 84, 86, 113, 210 💬 |
539 |
Tadalafil 20 mg film-coated tablets |
Tadalafil |
[1] D02008 D02008 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
540 |
Tadalafil 40 mg |
Tadalafil |
[1] D02008 D02008 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
541 |
Tadalafil and ambrisentan upfront combination therapy |
Ambrisentan |
[2] D02008 D02008, D07077 D07077 💬 |
EDNRA [2] EDNRA, PDE5A 💬 |
Calcium signaling pathway [9] Calcium signaling pathway, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 [2] 51, 86 💬 |
542 |
Tadalafil oral suspension |
Tadalafil |
[1] D02008 D02008 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
543 |
Tadalafil, placebo |
Tadalafil |
[1] D02008 D02008 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
544 |
Tadalafil- tablet or oral suspension |
Tadalafil |
[1] D02008 D02008 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
545 |
Tadalafilo |
Tadalafil |
[1] D02008 D02008 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
546 |
Tamoxifen |
Tamoxifen |
[2] D00966 D00966, D08559 D08559 💬 |
ESR1 [2] ESR1, ESR2 💬 |
Breast cancer [9] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
002 [4] 2 , 86, 113, 227 💬 |
547 |
Tasigna |
- |
- |
- |
- |
034 [2] 34, 86 💬 |
548 |
Tasigna® |
- |
- |
- |
- |
086 [1] 86 💬 |
549 |
Tasigna® 150 mg |
- |
- |
- |
- |
086 [1] 86 💬 |
550 |
Tbd |
- |
- |
- |
- |
019 [4] 19, 86, 276, 299 💬 |
551 |
Tegaderm |
- |
- |
- |
- |
086 [1] 86 💬 |
552 |
Terguride |
Terguride |
[1] D01348 D01348 💬 |
DRD2 [2] DRD2, PRL 💬 |
Alcoholism [12] Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway |
051 [2] 51, 86 💬 |
553 |
Terguride 0,5mg tablet |
Terguride |
[1] D01348 D01348 💬 |
DRD2 [2] DRD2, PRL 💬 |
Alcoholism [12] Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway |
086 [1] 86 💬 |
554 |
Terguride 0.5 mg tablet |
Terguride |
[1] D01348 D01348 💬 |
DRD2 [2] DRD2, PRL 💬 |
Alcoholism [12] Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway |
086 [1] 86 💬 |
555 |
Tezosentan |
Tezosentan |
- |
- |
- |
086 [1] 86 💬 |
556 |
The pop02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care: |
- |
- |
- |
- |
086 [1] 86 💬 |
557 |
The pops study is collecting pk data on children prescribed the following drugs of interest per standard of care: |
- |
- |
- |
- |
086 [1] 86 💬 |
558 |
Thelin |
- |
- |
- |
- |
086 [1] 86 💬 |
559 |
Threonine |
Threonine |
[1] D00041 D00041 💬 |
- |
- |
086 [3] 86, 96, 97 💬 |
560 |
Thrombin |
Thrombin |
[1] D00090 D00090 💬 |
- |
- |
086 [2] 86, 88 💬 |
561 |
Tocilizumab |
Tocilizumab |
[1] D02596 D02596 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
002 [18] 2 , 13, 40, 41, 42, 43, 46, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬 |
562 |
Tpn171h |
- |
- |
- |
- |
086 [1] 86 💬 |
563 |
Traclear |
- |
- |
- |
- |
086 [1] 86 💬 |
564 |
Tracleer |
- |
- |
- |
- |
013 [8] 13, 51, 84, 85, 86, 88, 210, 211 💬 |
565 |
Tracleer 62,5 mg comprimidos recubiertos con película |
- |
- |
- |
- |
086 [1] 86 💬 |
566 |
Tracleer 62,5mg 56cpr riv. |
- |
- |
- |
- |
086 [1] 86 💬 |
567 |
Tracleer*125mg 56cpr riv. |
- |
- |
- |
- |
051 [2] 51, 86 💬 |
568 |
Tracleer*56cpr riv 125mg |
- |
- |
- |
- |
051 [3] 51, 86, 88 💬 |
569 |
Tracleer® |
- |
- |
- |
- |
086 [1] 86 💬 |
570 |
Transdihydrolisuride |
- |
- |
- |
- |
051 [2] 51, 86 💬 |
571 |
Tre |
- |
- |
- |
- |
086 [1] 86 💬 |
572 |
Treprosinil diethanolamine |
- |
- |
- |
- |
086 [1] 86 💬 |
573 |
Treprostin |
- |
- |
- |
- |
086 [1] 86 💬 |
574 |
Treprostinil |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 [6] 51, 84, 85, 86, 88, 210 💬 |
575 |
Treprostinil dietanolamina |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
576 |
Treprostinil diethanolamine |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 [2] 51, 86 💬 |
577 |
Treprostinil diolamine |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
578 |
Treprostinil inhalation powder |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
579 |
Treprostinil inhalations |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
580 |
Treprostinil injectable product |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
581 |
Treprostinil sodium |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 [3] 51, 86, 88 💬 |
582 |
Treprostinil sodium solution for inhalation |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
583 |
Treprostinil sodium, ut-15 |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
584 |
Treprostinil, ut-15, lrx-15, 15au81, bw a15au, u-62, 840 |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
585 |
Treprostinilo |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
586 |
Trimetazidine |
Trimetazidine |
[2] D01606 D01606, D08642 D08642 💬 |
- |
- |
058 [2] 58, 86 💬 |
587 |
Trk-100stp |
- |
- |
- |
- |
086 [1] 86 💬 |
588 |
Tyrosine |
Tyrosine |
[1] D00022 D00022 💬 |
- |
- |
006 [3] 6 , 86, 111 💬 |
589 |
Tyvaso |
- |
- |
- |
- |
086 [1] 86 💬 |
590 |
Tyvaso inhalation solution |
- |
- |
- |
- |
086 [1] 86 💬 |
591 |
Ubenimex |
Ubenimex |
[1] D00087 D00087 💬 |
ANPEP [1] ANPEP 💬 |
Glutathione metabolism [4] Glutathione metabolism, Hematopoietic cell lineage, Metabolic pathways, Renin-angiotensin system |
086 [1] 86 💬 |
592 |
Udenafil |
Udenafil |
[1] D10027 D10027 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 [2] 86, 210 💬 |
593 |
Uk 092480 |
- |
- |
- |
- |
086 [1] 86 💬 |
594 |
Uk-92,480 |
- |
- |
- |
- |
086 [1] 86 💬 |
595 |
Uk-92,480-10 |
- |
- |
- |
- |
086 [1] 86 💬 |
596 |
Uptravi |
- |
- |
- |
- |
084 [3] 84, 86, 88 💬 |
597 |
Ut-15c |
- |
- |
- |
- |
086 [1] 86 💬 |
598 |
Ut-15c (treprostinil diethanolamine) |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
599 |
Ut-15c 0.25 mg |
- |
- |
- |
- |
086 [1] 86 💬 |
600 |
Ut-15c 1 mg |
- |
- |
- |
- |
086 [1] 86 💬 |
601 |
Ut-15c 5 mg |
- |
- |
- |
- |
086 [1] 86 💬 |
602 |
Ut-15c lp |
- |
- |
- |
- |
086 [1] 86 💬 |
603 |
Ut-15c sr |
- |
- |
- |
- |
051 [2] 51, 86 💬 |
604 |
Ut-15c sr (treprostinil diethanolamine) |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
605 |
Ut-15c-sr |
- |
- |
- |
- |
051 [2] 51, 86 💬 |
606 |
Vardenafil |
Vardenafil |
[3] D02731 D02731, D03260 D03260, D08668 D08668 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
013 [3] 13, 86, 299 💬 |
607 |
Vasomera (pb1046) injection |
- |
- |
- |
- |
086 [1] 86 💬 |
608 |
Veletri |
- |
- |
- |
- |
086 [1] 86 💬 |
609 |
Ventavis |
- |
- |
- |
- |
086 [1] 86 💬 |
610 |
Ventavis (iloprost, bayq6256) |
Iloprost |
[1] D02721 D02721 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
611 |
Ventavis 10 |
- |
- |
- |
- |
086 [1] 86 💬 |
612 |
Ventavis(iloprost) |
Iloprost |
[1] D02721 D02721 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
613 |
Viagra |
- |
- |
- |
- |
086 [3] 86, 96, 225 💬 |
614 |
Vip |
- |
- |
- |
- |
049 [3] 49, 51, 86 💬 |
615 |
Volibris |
- |
- |
- |
- |
051 [4] 51, 85, 86, 88 💬 |
616 |
Volibris 10 mg comprimidos recubiertos con película |
- |
- |
- |
- |
086 [1] 86 💬 |
617 |
Volibris 5 mg comprimidos recubiertos con película |
- |
- |
- |
- |
086 [1] 86 💬 |
618 |
Volibris® (ambrisentan) |
Ambrisentan |
[1] D07077 D07077 💬 |
EDNRA [1] EDNRA 💬 |
Calcium signaling pathway [7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
619 |
Volibris™ tablets |
- |
- |
- |
- |
086 [1] 86 💬 |
620 |
Zamicastat |
Zamicastat |
- |
- |
- |
086 [1] 86 💬 |